Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$113.62 - $135.39 $1.07 Million - $1.28 Million
-9,441 Reduced 3.17%
288,505 $37.6 Million
Q2 2024

Jul 29, 2024

BUY
$89.48 - $118.35 $46,977 - $62,133
525 Added 0.18%
297,946 $35.3 Million
Q1 2024

Apr 29, 2024

SELL
$76.4 - $96.33 $3,667 - $4,623
-48 Reduced 0.02%
297,421 $28 Million
Q4 2023

Feb 07, 2024

SELL
$59.53 - $85.11 $6.02 Million - $8.6 Million
-101,103 Reduced 25.37%
297,469 $23.6 Million
Q3 2023

Nov 02, 2023

BUY
$69.23 - $79.09 $3.59 Million - $4.1 Million
51,851 Added 14.95%
398,572 $30 Million
Q2 2023

Aug 07, 2023

BUY
$45.44 - $71.21 $2.02 Million - $3.17 Million
44,487 Added 14.72%
346,721 $24.7 Million
Q1 2023

May 09, 2023

SELL
$43.88 - $52.48 $345,116 - $412,755
-7,865 Reduced 2.54%
302,234 $15.1 Million
Q4 2022

Feb 09, 2023

BUY
$40.82 - $57.75 $27,431 - $38,808
672 Added 0.22%
310,099 $13.5 Million
Q3 2022

Nov 09, 2022

SELL
$46.84 - $58.49 $808,552 - $1.01 Million
-17,262 Reduced 5.28%
309,427 $16.5 Million
Q2 2022

Aug 10, 2022

BUY
$34.86 - $63.77 $128,842 - $235,693
3,696 Added 1.14%
326,689 $14.8 Million
Q1 2022

May 09, 2022

SELL
$44.33 - $57.82 $103,421 - $134,894
-2,333 Reduced 0.72%
322,993 $18.7 Million
Q4 2021

Feb 09, 2022

BUY
$40.27 - $56.99 $13.1 Million - $18.5 Million
325,326 New
325,326 $14.5 Million
Q4 2019

Feb 05, 2020

SELL
$54.18 - $65.64 $1.36 Million - $1.65 Million
-25,115 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$58.58 - $83.91 $65,609 - $93,979
1,120 Added 4.67%
25,115 $1.57 Million
Q2 2019

Aug 12, 2019

BUY
$63.59 - $78.71 $377,470 - $467,222
5,936 Added 32.87%
23,995 $1.81 Million
Q1 2019

May 10, 2019

BUY
$50.75 - $80.54 $190,160 - $301,783
3,747 Added 26.18%
18,059 $1.42 Million
Q4 2018

Feb 14, 2019

BUY
$52.18 - $67.93 $218,164 - $284,015
4,181 Added 41.27%
14,312 $804,000
Q3 2018

Nov 14, 2018

BUY
$38.13 - $68.37 $193,433 - $346,841
5,073 Added 100.3%
10,131 $657,000
Q2 2018

Aug 13, 2018

SELL
$27.62 - $44.51 $683,014 - $1.1 Million
-24,729 Reduced 83.02%
5,058 $0
Q1 2018

May 14, 2018

BUY
$26.05 - $34.5 $71,533 - $94,737
2,746 Added 10.15%
29,787 $918,000
Q4 2017

Feb 13, 2018

BUY
$24.5 - $36.01 $264,673 - $389,016
10,803 Added 66.53%
27,041 $694,000
Q3 2017

Nov 02, 2017

BUY
$31.26 - $42.03 $507,599 - $682,483
16,238
16,238 $536,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.